StockMarketWire.com - Liberum Capital today reaffirms its hold investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 6400p (from 5800p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk